ARCHIVES

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

November 18, 2005

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994